Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $75.12 | $17.95 | 318.57% | 313.00x | 21.99x | 22.95x | 61.52x | 1.54x | $41.15M | 0.62% | $108.58M | 1.23 | $6.64B | 123.93 | ||
| CORT | CORCEPT THERAPEUTICS INC | $87.89 | $21.09 | 316.81% | 191.07x | 167.86x | 11.94x | 14.79x | 1.61x | $119.79M | 1.31% | $637.99M | 6.11 | $9.34B | -1,359.75 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $7.74 | $2.97 | 160.40% | 110.57x | 72.27x | 4.19x | 102.70x | 1.02x | $47.52M | 3.60% | $13.01M | 0.08 | $1.48B | 27.76 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $293.52 | $95.04 | 208.83% | 67.32x | 38.92x | 9.10x | 36.44x | 1.40x | $641.34M | 1.64% | $1.08B | 8.09 | $40.45B | 43.75 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.41 | $17.60 | 254.53% | 63.68x | 48.88x | 6.33x | 7.93x | 1.72x | $164.23M | 3.44% | $605.69M | 7.92 | $4.62B | 41.45 | ||
| KRYS | KRYSTAL BIOTECH INC | $378.15 | $96.94 | 290.09% | 48.79x | 47.56x | 26.54x | 8.73x | 2.33x | $237.38M | 2.14% | $1.28B | 43.59 | $10.66B | 49.80 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.18 | $72.50 | 6.45% | 26.07x | 9.31x | 6.04x | 41.68x | 0.47x | $667.65M | 7.32% | $219.64M | 1.86 | $10.99B | 17.61 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.67 | $42.46 | 35.82% | 41.19x | 15.21x | 3.42x | 1.79x | 0.56x | $767.06M | 6.91% | $6.21B | 32.27 | $9.50B | 19.70 | ||
| RPRX | ROYALTY PHARMA PLC | $57.09 | $40.53 | 40.85% | 29.89x | 10.70x | 10.22x | 3.31x | 0.64x | $2.34B | 9.39% | $9.94B | 22.75 | $41.24B | 35.45 | ||
| ADMA | ADMA BIOLOGICS INC | $8.37 | $9.99 | -16.23% | 12.13x | 9.15x | 3.88x | 4.97x | 0.45x | $107.90M | 5.46% | $390.33M | 1.65 | $2.00B | 9.03 | ||
| VCEL | VERICEL CORP | $45.07 | $9.29 | 385.39% | 104.81x | 93.49x | 7.83x | 6.46x | 2.20x | $47.49M | 2.07% | $356.23M | 7.02 | $2.29B | 56.58 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $14.01 | $16.23 | -13.66% | 6.83x | 29.22x | 6.69x | 4.02x | 0.91x | $56.42M | 6.90% | $205.80M | 3.52 | $733.75M | 5.07 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $237.72 | $50.21 | 373.48% | 505.79x | 9.24x | 3.32x | 3.29x | 1.70x | $1.30B | 8.82% | $4.53B | 73.22 | $18.47B | 27.37 | ||
| ASND | ASCENDIS PHARMA A | $263.70 | $82.01 | 221.54% | 27.95x | 17.68x | 16.08x | 28.53x | 2.86x | $52.94M | 0.32% | $574.09M | 9.24 | $16.76B | 179.72 | ||
| TGTX | TG THERAPEUTICS INC | $55.72 | $17.31 | 221.85% | 17.30x | 39.84x | 11.49x | 14.63x | 274.21x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.84B | 58.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.34 | $36.33 | -2.72% | 13.97x | 9.60x | 2.27x | 2.25x | 0.53x | $341.79M | 16.73% | $910.35M | 15.75 | $1.62B | 6.82 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $314.04 | $95.92 | 227.39% | 39.75x | 34.60x | 22.75x | 6.31x | 2.00x | $122.22M | 1.96% | $997.32M | 50.16 | $6.63B | 29.40 | ||
| TECH | BIO-TECHNE CORP | $70.90 | $15.57 | 355.40% | 99.86x | 33.93x | 9.15x | 5.32x | 2.06x | $269.60M | 2.43% | $2.09B | 13.34 | $11.18B | 43.68 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.26 | $5.83 | -61.23% | 8.37x | 3.31x | 2.12x | 2.47x | 0.18x | $7.24M | 5.58% | $52.93M | 0.92 | $77.20M | 4.98 | ||
| EXEL | EXELIXIS INC | $54.28 | $31.35 | 73.16% | 17.40x | 16.48x | 5.90x | 7.05x | 1.27x | $917.69M | 6.54% | $1.94B | 7.49 | $13.59B | 12.87 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $499.65 | $170.66 | 192.77% | 29.37x | 25.56x | 10.39x | 6.55x | 2.14x | $3.71B | 2.92% | $19.36B | 76.20 | $123.31B | 22.86 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.30 | $2.50 | 32.02% | 13.75x | 13.95x | 2.02x | 3.19x | 0.93x | $4.11M | 1.55% | $82.33M | 1.03 | $198.85M | 9.36 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.46 | $12.45 | 152.76% | 17.38x | 16.04x | 6.44x | 3.80x | 3.90x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.24 | ||
| UTHR | UNITED THERAPEUTICS CORP | $544.92 | $247.20 | 120.44% | 18.61x | 19.15x | 7.48x | 3.92x | 2.06x | $1.02B | 4.29% | $5.90B | 135.66 | $21.85B | 12.75 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $631.81 | $443.08 | 42.59% | 14.85x | 13.43x | 4.40x | 2.11x | 1.00x | $4.11B | 6.26% | $31.42B | 302.15 | $65.98B | 11.49 | ||
| INCY | INCYTE CORP | $114.66 | $67.95 | 68.75% | 15.73x | 14.64x | 4.26x | 4.07x | 1.35x | $1.45B | 6.35% | $5.62B | 28.21 | $19.48B | 10.41 | ||
| VCYT | VERACYTE INC | $60.19 | $7.72 | 679.27% | 54.23x | 53.97x | 8.84x | 3.57x | 11.55x | $155.34M | 3.24% | $1.34B | 16.90 | $4.58B | 39.79 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.02 | $3.67 | 364.29% | 28.37x | 4.64x | 0.82x | 1.19x | 12.84x | $109.24M | 6.11% | $1.51B | 14.34 | $2.37B | 28.64 | ||
| MDXG | MIMEDX GROUP INC | $3.91 | $1.28 | 206.58% | 18.62x | -46.44x | 1.49x | 2.40x | 8.85x | $69.36M | 11.94% | $242.94M | 1.64 | $440.20M | 8.08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.